Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Amplify Weight Loss Drug & Treatment ETF THNR

Full chart Compare
Set alert

Price alert · THNR

All alert types
26.50 USD +0.85 (+3.31%)

Nov 4, 2026, 11:46 AM EST

26.34 Day range 26.58
23.40 52-week range 27.94
YTD
+5.06%
1 year
+14.40%

Amplify Weight Loss Drug & Treatment ETF

Issuer
Amplify
Asset class
Equity
Expense ratio
0.59%
Assets under management
$5.96M
NAV
25.89
Holdings
20
Inception
2024-05-21
Top 10 weight
66.70%

Top holdings

  1. LLY Eli Lilly & Co 12.00%
  2. NVO Novo Nordisk A/S 8.73%
  3. REGN Regeneron Pharmaceuticals Inc 6.26%
  4. AMGN Amgen Inc 6.15%
  5. AZN AstraZeneca PLC 5.88%
  6. GILD Gilead Sciences Inc 5.74%
  7. ROP.SW Roche Holding AG 5.71%
  8. ABBV AbbVie Inc 5.56%
  9. PFE Pfizer Inc 5.53%
  10. 4519.T Chugai Pharmaceutical Co Ltd 5.12%
  11. MRK Merck & Co Inc 4.96%
  12. 1093.HK CSPC Pharmaceutical Group Ltd 4.44%
  13. 1801.HK Innovent Biologics Inc 4.20%
  14. VKTX Viking Therapeutics Inc 4.03%
  15. ARWR Arrowhead Pharmaceuticals Inc 3.57%
  16. ZEAL.CO Zealand Pharma A/S 3.29%
  17. 128940.KS Hanmi Pharm Co Ltd 2.88%
  18. 1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd 2.35%
  19. GPCR Structure Therapeutics Inc 2.10%
  20. KLRA Kailera Therapeutics Inc 1.06%
  21. Cash & Other 0.22%
  22. AGPXX Invesco Government & Agency Portfolio 12/31/2031 0.20%

Sector weights

  • Healthcare 99.55%
  • Financial Services 0.26%
  • Cash & Others 0.19%

Country weights

  • United States 57.17%
  • Denmark 11.97%
  • China 11.40%
  • Switzerland 5.93%
  • United Kingdom 5.68%
  • Japan 5.09%
  • South Korea 2.77%

Updated 2026-11-03